Skip to content
Last Updated:
Monday, March 27, 2023
8:38 AM
USA
CytoDyn
CytoDyn is a biotechnology company focused on developing innovative treatments for multiple therapeutic indications based on Leronlimab (PRO 140).
Stock Quote
CytoDyn is a biotechnology company focused on developing innovative treatments for multiple therapeutic indications based on Leronlimab (PRO 140).
Newsroom
Stock Quote
Vaccine
Treatment
Testing
Stats
Infographics
Menu
Vaccine
Treatment
Testing
Stats
Infographics